Corbus Pharmaceuticals Holdings Inc

+0.07 (+6.86%)
Earnings Announcements

Corbus Pharmaceuticals Reports Q4 Loss Per Share $0.10

Published: 03/15/2021 11:39 GMT
Corbus Pharmaceuticals Holdings Inc (CRBP) - Corbus Pharmaceuticals Reports Fourth Quarter and Year-end 2020 Financial Results.
Q4 Loss per Share $0.10.
Q4 Earnings per Share Estimate $-0.25 -- Refinitiv Ibes Data (analyst estimates).
Corbus Pharmaceuticals Holdings - Revenue From Awards and Licenses Was $700,000 for Three Months Ended Dec.
31, 2020 Versus $2.6 Million.
Revenue is expected to be $0.89 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $1.17 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.